Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 14, 2025 09:00 ET | Source: Research and Markets

HER2+ Gastric Cancer Market Analysis and Forecast Report 2025-2035: AstraZeneca, Merck, and Roche Lead Innovation in HER2+ Gastric Cancer Therapies

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "HER2+ Gastric Cancer Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ...
April 03, 2025 04:04 ET | Source: Research and Markets

Gastric Cancer Research Report 2025: A $14.5 Billion Market by 2032, Growing with a CAGR of 13% Featuring AstraZeneca, Pfizer, Novartis, Amgen, and AbbVie

Dublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Gastric Cancer Market" report has been added to ResearchAndMarkets.com's offering. The latest analysis on the gastric cancer market reveals a...
January 23, 2025 04:48 ET | Source: Research and Markets

Gastric Cancer Market Research by Diagnosis, Treatment, Route of Administration, End-users, and Region - Global Market to Grow by Over $15 Billion During 2023-2034

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Gastric Cancer Market by Type, by Diagnosis, by Treatment, by Route of Administration, by End-users, and by Region" report has been added to ...
November 20, 2024 07:55 ET | Source: Research and Markets

Gastric Cancer Industry Analysis and Forecast to 2034 - Insights on the Global Market's Rapid Growth to $18.43 Billion, Emerging Therapies, and Regional Trends

Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Gastric Cancer Market by Type, by Diagnosis, by Treatment, by Route of Administration, by End-users, and by Region" report has been added to ...
September 11, 2024 11:03 ET | Source: Research and Markets

Gastric Cancer Market Research Report 2024-2030 by Immunotherapy, Chemotherapy, Radiation Therapy, Surgery, Target Therapies, PD-1/PD-L1 Inhibitors, HER2 Antagonists VEGFR2 Antagonists

Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Gastric Cancer Market (2024 Edition): Analysis By Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal...
June 01, 2023 09:02 ET | Source: Research Dive

Global Gastric Cancer Market Expected to Accumulate a Revenue of $10,737.00 Million by 2031, Growing at a Healthy CAGR of 17.9% [350-Pages] | Initiative by Research Dive

New York, USA, June 01, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global gastric cancer market is anticipated to rise at a stable CAGR of 17.9%, thereby...
April 14, 2023 11:33 ET | Source: Allied Market Research

Gastric Cancer Market Is Expected to Reach $10.7 Billion by 2031: Allied Market Research

Portland, OR, April 14, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global gastric cancer market generated $2.1 billion in 2021, and is estimated to...
January 28, 2021 06:33 ET | Source: Research and Markets

Global Gastric Cancer Forecast and Market Analysis Report 2020-2027 - Trastuzumab Biosimilars are Now Available, Leading to a Sharp Decline in the Market Share of Herceptin

Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Gastric Cancer Forecast and Market Analysis" drug pipelines has been added to ResearchAndMarkets.com's offering. The report estimates that in 2018,...
February 11, 2020 01:39 ET | Source: Fortune Business Insights

Stomach Cancer/Gastric Cancer Treatment Market to Reach USD 8.20 Billion by 2026; Rapid Adoption of PD-1 Inhibitors for Treating Gastric Cancers to Boost the Market: Fortune Business Insights™

Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Stomach Cancer Treatment Market size is expected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3% during the forecast period. One of...